Large gap with delayed quotes
|
Last quote
10/20/2025
-
15:44:13
|
Bid
10/20/2025 -
15:44:13
|
Bid Volume |
Ask
10/20/2025 -
15:44:13
|
Ask Volume |
|---|---|---|---|---|
|
63.15
+1.29
(
+2.09% )
|
62.78
|
200 |
63.15
|
100 |
Analysis date: 17.10.2025
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 17.10.2025.
Interest
Strong
Strong
Three stars since 07.10.2025.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 07.10.2025 at a price of 59.19.
Evaluation
Overvalued
Overvalued
Based on its growth potential and our own criteria, we believe the share price is currently moderately overvalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 30.09.2025.
4wk Rel Perf
18.60%
18.60%
The four-week dividend-adjusted overperformance versus SP500 is 18.60%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 17.10.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 3.31%.
Mkt Cap in $bn
9.63
9.63
With a market capitalization >$8bn, BIO-TECHNE is considered a large-cap stock.
G/PE Ratio
0.68
0.68
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) below 0.9 indicates that investors must pay a premium for the estimated growth potential:
LT P/E
27.69
27.69
The estimated PE is for the year 2027.
LT Growth
18.17%
18.17%
The annualized growth estimate is for the current year to 2027.
Avg. Nb analysts
14
14
Over the last seven weeks, an average of 14 analysts provided earnings per share estimates.
Dividend Yield
0.52%
0.52%
The twelve month estimated dividend yield represents 14.33% of earnings forecasts.
Beta
93
93
For 1% of index variation, the stock varies on average by 0.93%.
Correlation
0.44
0.44
43.68% of stock movements are explained by index variations.
Value at Risk
14.85
14.85
The value at risk is estimated at USD 14.85. The risk is therefore 24.00%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
31.03.2004
31.03.2004